Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh (REGN34) Stock Price & Analysis

REGN34 Stock Chart & Stats

R$83.72R$10.99(15.11%)

At close: Oct 30

Day’s Range: BRL 76.37 - BRL 84.06
52-Week Range: BRL 44.82 - BRL 84.06
Previous Close: BRL 72.73
Volume: N/A
Average Volume (3M): 1,147
Market Cap: BRL 519.31B
Enterprise Value: BRL 316.27B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 21466.7
Beta: -0.54
Next Earnings: Jan 29, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: 0.26%

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh News

Regeneron price target raised to $925 from $750 at Wells Fargo

Wells Fargo raised the firm’s price target on Regeneron (REGN) to $925 from $750 and keeps an Equal Weight rating on the shares. The firm cites the company’s strong commercial

9h agoREGN RGO

Regeneron price target raised to $1,030 from $908 at BofA

BofA raised the firm’s price target on Regeneron (REGN) to $1,030 from $908 and keeps a Buy rating on the shares. The company reported solid Q3 results across key products,

9h agoREGN RGO

Regeneron’s Strong Commercial Execution and Pipeline Catalysts Drive Price Target Increase to $1,030

Bank of America Securities analyst Tazeen Ahmad reiterated a Buy rating on Regeneron on October 30 and set a price target of $1,030.00. Tazeen Ahmad’s rating is based on Regeneron’s

9h agoREGN RGO

Regeneron price target raised to $855 from $779 at Morgan Stanley

Morgan Stanley analyst Terence Flynn raised the firm’s price target on Regeneron (REGN) to $855 from $779 and keeps an Equal Weight rating on the shares. The firm views the

9h agoREGN RGO

Regeneron price target raised to $1,000 from $865 at Piper Sandler

Piper Sandler analyst Biren Amin raised the firm’s price target on Regeneron (REGN) to $1,000 from $865 and keeps an Overweight rating on the shares. Published first on TheFly –

2d agoREGN RGO

Regeneron price target raised to $1,050 from $950 at JPMorgan

JPMorgan raised the firm’s price target on Regeneron (REGN) to $1,050 from $950 and keeps an Overweight rating on the shares after the company reported a meaningful Q3 beat, driven

2d agoREGN RGO

Regeneron price target raised to $1,020 from $911 at Raymond James

Raymond James raised the firm’s price target on Regeneron (REGN) to $1,020 from $911 and keeps an Outperform rating on the shares. The firm raised its price target following a

2d agoREGN RGO

Regeneron price target raised to $825 from $740 at Citi

Citi raised the firm’s price target on Regeneron (REGN) to $825 from $740 and keeps a Neutral rating on the shares. The firm upped Regeneron’s estimates post the better than

2d agoREGN RGO

Regeneron rises 13.1%

Regeneron (REGN) is up 13.1%, or $107.09 to $925.86. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on

2d agoREGN RGO

Early notable gainers among liquid option names on October 30th

Notable gainers among liquid option names this morning include FedEx Freight Holding Company Inc (FDXF) $124.13 +14.44, Regeneron (REGN) $925.58 +106.81, Veralto Corp (VLTO) $113.22 +9.16, CBOE Holdings (CBOE) $332.27

2d agoCBOE DXCM

Video: Amazon and Intel reports, Binance hack hitting sentiment

The Fly has brought its to-the-moment stock market reporting to YouTube! Subscribe if you want to know how the markets will open, which stocks will be moving and why. Published

2d agoAMZN COIN

Regeneron: Strong Execution, Growth Visibility and Pipeline Catalysts Drive Price Target Increase to $891

In a report released yesterday, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Regeneron, with a price target of $891.00. Tazeen Ahmad has given his Buy

3M agoREGN RGO

REGN34 FAQ

What was Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s price range in the past 12 months?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh lowest stock price was R$44.82 and its highest was R$84.06 in the past 12 months.

What is Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s market cap?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s market cap is R$519.31B.

When is Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s earnings last quarter?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh released its earnings results on Oct 30, 2026. The company reported R$0.002 earnings per share for the quarter.

Is Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh pay dividends?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh does not currently pay dividends.

What is Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s EPS estimate?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh have?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh has 6,067,057,000 shares outstanding.

What happened to Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh’s price movement after its last earnings report?

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh reported an EPS of R$0.002 in its last earnings report. Following the earnings report the stock price went up 15.111%.

Which hedge fund is a major shareholder of Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh?

Currently, no hedge funds are holding shares in BR:REGN34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh (REGN34) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	15	1	6
Technical Analysis	3	1	6
Moving Averages	12	0	0

Technical Analysis >

Similar Stocks

Stocks similar to BR:REGN34
Company	Price & Change	Follow
BR:A1RG34arGEN-X SE ADR Unsponsored Brazilian Depositary Receipt Repr 0.04 ADR
BR:TAKP34Takeda Pharmaceutical Co. Ltd. Unsponsored Brazilian Depository Receipt Repr 1 ADR

Compare BR:REGN34 Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

REGN34 Stock Chart & Stats

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh News

Regeneron price target raised to $925 from $750 at Wells Fargo

Regeneron price target raised to $1,030 from $908 at BofA

Regeneron’s Strong Commercial Execution and Pipeline Catalysts Drive Price Target Increase to $1,030

Regeneron price target raised to $855 from $779 at Morgan Stanley

Regeneron price target raised to $1,000 from $865 at Piper Sandler

Regeneron price target raised to $1,050 from $950 at JPMorgan

Regeneron price target raised to $1,020 from $911 at Raymond James

Regeneron price target raised to $825 from $740 at Citi

Regeneron rises 13.1%

Early notable gainers among liquid option names on October 30th

Video: Amazon and Intel reports, Binance hack hitting sentiment

Regeneron: Strong Execution, Growth Visibility and Pipeline Catalysts Drive Price Target Increase to $891

REGN34 FAQ

Regeneron Pharmaceuticals, Inc.Shs Unsponsored Brazilian Depositary Receipt Repr 0.0166667 Sh (REGN34) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium